EMRNEUTRAL

EMR EV/EBITDA Analysis

16.4x

Updated 105h ago·SEC filings & market data

Key Takeaway

EV/EBITDA compares a company’s total value to its operating earnings, and a 17.0x multiple means investors pay $17 for every $1 of EBITDA.

Sector Performance

62th percentile

EMR

16.4x

Sector Median

13.6x

Sector Avg

-30.9x

Prior Period

17.0x(Aug 2026)

↑ Improving
📊

Deep Analysis

EV/EBITDA compares a company’s total value to its operating earnings, and a 17.0x multiple means investors pay $17 for every $1 of EBITDA.

That is above the sector median of 13.6x, placing EMR in the 64th percentile among peers. The metric has been increasing over the last 8 quarters, with the latest quarter up 0.9% quarter-over-quarter; the year-over-year change is not available. The combination of a premium valuation and an upward trend suggests investors are pricing in continued earnings growth, which carries downside risk if growth stalls. This supports the overall NEUTRAL verdict: the positive momentum is balanced by the higher multiple and lack of a clear margin of safety.

Frequently Asked Questions

What does the EV/EBITDA tell investors about EMR?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

Who are EMR's closest peers by EV/EBITDA?

The closest peers by EV/EBITDA include: SMTC (76.6x), SHOP (80.2x), OKTA (83.5x), TEAM (101.4x), STEM (102.7x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

Advertisement

Master EMR's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full EMR research report

Free account — no credit card

EMR

16.4x

Sector Median

13.6x

Sector Avg

-30.9x

How EMR's EV/EBITDA compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.